Suven Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | NSE: SUVENPHAR | BSE: 543064
₹1,224.25 
13.70 (1.13 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 1,208.20
High (₹) 1,230.00
Low (₹) 1,177.20
Prev. Close (₹) 1,210.55
Volume 17,337
VWAP (₹) 1,207.44
ROCE (%) 19.24
Industry P/E 43.99
TTM P/E 111.60
P/B Ratio 15.22
Market Cap (₹) Cr.31,221.12
Dividend Yield (%)--
EPS (₹) 11.80
ROE14.65%
Sales Growth (%) -21.56
Profit Growth (%)-26.99
Day Range
1,230.001,230.00
52 Week Range
597.001,359.00
Historical Returns
Returns (6M)
13.95 %
Returns (1Y)
84.5 %
Returns (3Y)
133.95 %
Returns (5Y)
628.72 %
Returns (6M)
13.95 %
Returns (1Y)
84.5 %
Returns (3Y)
133.95 %
Returns (5Y)
628.72 %
SWOT Analysis
- Company with Low Debt
- Book value per share improving over the last 2 years
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- High CCI indicates strong upward momentum.
- Positive ROC (9) indicates upward momentum.
- Strong trend indicated by ADX above 25.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
BEARISHRSI 62.61
MFI 78.68
ATR 68.90
Commodity Channel Index 145.72
ROC125 14.46
ROC21 21.90
Williams %R -33.95
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 1,244.66 | 1,263.73 | 1,297.46 | 1,210.93 | 1,191.86 | 1,158.13 | 1,139.06 |
| Week Ago | 1,114.01 | 1,139.83 | 1,160.81 | 1,093.03 | 1,067.21 | 1,046.23 | 1,020.41 |
| Month Ago | 1,082.36 | 1,109.18 | 1,128.36 | 1,063.18 | 1,036.36 | 1,017.18 | 990.36 |
EMA & SMA
1224.25
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 1148.27
9 Day 1119.05
10 Day 1125.53
12 Day 1132.30
14 Day 1132.93
20 Day 1095.30
26 Day 1088.67
50 Day 1123.18
100 Day 1188.96
200 Day 1033.41
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| BNP PARIBAS ARBITRAGE | block | Sell | 25 Jan, 2024 | ₹685.15 | 2,97,913 | BSE |
| SOCIETE GENERALE | block | Buy | 25 Jan, 2024 | ₹685.15 | 2,97,913 | BSE |
| MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND | block | Buy | 25 Jan, 2024 | ₹685.15 | 1,76,249 | BSE |
| MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND | block | Buy | 25 Jan, 2024 | ₹685.15 | 7,449 | BSE |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 17 Oct, 2022 | ₹406.40 | 56,772 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 17 Oct, 2022 | ₹406.40 | 5,03,350 | BSE |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 17 Oct, 2022 | ₹406.40 | 56,772 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 17 Oct, 2022 | ₹406.40 | 5,03,350 | BSE |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11 Oct, 2022 | ₹419.65 | 27,617 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 11 Oct, 2022 | ₹419.65 | 2,44,874 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 30 Sept, 2023 | JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED in its capacity as sole Trustee of the Jasti Family Trust | Disposal | ₹495.00 | 12,75,37,043 | BSE |
| 14 Aug, 2023 | PADMAJA J.A.S | Disposal | ₹501.7725 | 28,000 | BSE |
| 17 Feb, 2023 | PADMAJA J.A.S | Disposal | ₹482.2465714285714285714285714 | 7,000 | BSE |
| 02 Sept, 2020 | PADMAJA J.A.S | Acquisition | ₹640.6396 | 5,000 | BSE |
| 31 Aug, 2020 | PADMAJA J.A.S | Acquisition | ₹688.1544 | 2,500 | BSE |
| 27 Aug, 2020 | PADMAJA J.A.S | Acquisition | ₹702.8044 | 5,000 | BSE |
| 24 Aug, 2020 | PADMAJA J.A.S | Acquisition | ₹685.7422 | 5,000 | BSE |
| 04 Jul, 2020 | PADMA KUMAR R | Acquisition | ₹470.3067 | 10,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 30 Aug, 2022 | Rs.5.0000 per share(500%)Special Dividend | 09 Sept, 2022 | 12 Sept, 2022 |
| 29 Aug, 2022 | Rs.1.0000 per share(100%)Interim Dividend | 09 Sept, 2022 | 12 Sept, 2022 |
| 03 May, 2022 | Rs.1.0000 per share(100%)Special Dividend | 13 May, 2022 | 17 May, 2022 |
| 17 Aug, 2020 | Bonus issue in the ratio of 1:1 of Re. 1/-. | 25 Sept, 2020 | 28 Sept, 2020 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 20 Feb, 2025 | BSE India | Analyst Day |
| 20 Feb, 2025 | NSE India | Suven Pharmaceuticals Limited has informed the Exchange about Schedule of meet |
| 18 Feb, 2025 | BSE India | Earnings call Transcript |
| 18 Feb, 2025 | NSE India | Suven Pharmaceuticals Limited has informed the Exchange about Transcript |
| 13 Feb, 2025 | NSE India | Suven Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication |
| 12 Feb, 2025 | BSE India | Audio link of the Conference Call |
| 12 Feb, 2025 | NSE India | Suven Pharmaceuticals Limited has informed the Exchange about Link of Recording |
| 12 Feb, 2025 | BSE India | Integrated Filing-Financials for Q3FY25 |
| 12 Feb, 2025 | NSE India | Integrated filing - Financials for Q3FY25 |
| 12 Feb, 2025 | NSE India | Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 28 Dec, 2024 | 12 Feb, 2025 |
| Quarterly Results | -- | 01 Oct, 2024 | 12 Nov, 2024 |
| Quarterly Results | -- | 05 Aug, 2024 | 09 Aug, 2024 |
| Audited Results | (Revised) | 22 May, 2024 | 30 May, 2024 |
| Quarterly Results | -- | 22 May, 2024 | 05 Feb, 2024 |
| Quarterly Results | -- | 03 Nov, 2023 | 09 Nov, 2023 |
| Quarterly Results | -- | 03 Aug, 2023 | 08 Aug, 2023 |
| Audited Results | -- | 19 May, 2023 | 25 May, 2023 |
| Quarterly Results | -- | 31 Jan, 2023 | 06 Feb, 2023 |
| Quarterly Results | -- | 02 Nov, 2022 | 08 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Suven Pharmaceuticals
Suven Pharmaceuticals is a Public Limited Listed company incorporated on 06/11/2018 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24299MH2018PLC422236 and registration number is 422236. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1024.99 Cr. and Equity Capital is Rs. 25.46 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2018
Managing Director
Dr. V Prasada Raju
NSE Symbol
SUVENPHAR
Suven Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Annaswamy Vaidheesh | Executive Chairperson |
| Dr. V Prasada Raju | Managing Director |
| Mr. Pankaj Patwari | Non Executive Director |
| Ms. Shweta Jalan | Non Executive Director |
| Ms. Matangi Gowrishankar | Independent Director |
| Mr. Vinod Rao | Independent Director |
| Mr. K G Ananthakrishnan | Independent Director |
| Mr. Pravin Rao Udhyavara Bhadya | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Suven Pharmaceuticals
What is the share price of Suven Pharmaceuticals?
The share price of Suven Pharmaceuticals on 21 Feb, 2025 is ₹ 1,224.25.
What is 52W high and 52W low share price of Suven Pharmaceuticals?
The highest and lowest 52W share prices of Suven Pharmaceuticals are ₹ 1359.000 and ₹ 586.100
What is the market cap of Suven Pharmaceuticals?
The market capitalization of Suven Pharmaceuticals as of 21 Feb, 2025 is ₹ 31,221.12 Crores
What is the P/E ratio of Suven Pharmaceuticals?
The current P/E ratio of Suven Pharmaceuticals as of 21 Feb, 2025 is 43.99
What is the PB ratio of Suven Pharmaceuticals?
The PB ratio of Suven Pharmaceuticals as of 21 Feb, 2025 is 15.22
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)